Conference Code: 13TH12ICTT
Conference Aims and Objectives
The ICTT 2013: 15th International Conference on Tuberculosis Therapy
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Tuberculosis Therapy. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Tuberculosis Therapy.
Call for Contributions
All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Tuberculosis Therapy are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.WASET
All submitted conference papers will be blind peer reviewed by three competent reviewers. The post conference proceedings will be abstracted and indexed in the International Science Index
, and submitted to be indexed in the
, Scopus and Thomson Reuters. The conference abstracts and proceedings book, CD and certificate of presentation will be distributed to participants at the conference registration desk.
Special Journal Issues
has teamed up with the Special Journal Issue on Tuberculosis Therapy
A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form
|Abstracts/Full-Text Paper Submission Deadline
||November 11, 2013
|Notification of Acceptance/Rejection
||November 21, 2013
|Final Paper (Camera Ready) Submission & Early Bird Registration Deadline
||November 30, 2013
||December 24 - 25, 2013
Please ensure your submission meets WASET's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for
Please refer to the Paper Submission GUIDE
before submitting your paper.
Selected Conference Papers
1) The Role of Chemokine Family, CXCL-10 Urine as a Marker Diagnosis of Active Lung Tuberculosis in HIV/AIDS PatientsDwitya Elvira, Raveinal Masri, Rohayat Bilmahdi 2) Evaluation of Disease Risk Variables in the Control of Bovine TuberculosisBerrin Şentürk 3) Statistical Analysis of Interferon-γ for the Effectiveness of an Anti-Tuberculous TreatmentShishen Xie, Yingda L. Xie 4) Impact of Tuberculosis Co-infection on Cytokine Expression in HIV-Infected IndividualsM. Nosik, I. Rymanova, N. Adamovich, S. Sevostyanihin, K. Ryzhov, Y. Kuimova, A. Kravtchenko, N. Sergeeva, A. Sobkin 5) Development of a Mobile Image-Based Reminder Application to Support Tuberculosis Treatment in AfricaHaji Ali Haji, Hussein Suleman, Ulrike Rivett 6) Surface Thermodynamics Approach to Mycobacterium tuberculosis (M-TB) – Human Sputum InteractionsJ. L. Chukwuneke, C. H. Achebe, S. N. Omenyi 7) In silico Analysis of Isoniazid Resistance in Mycobacterium tuberculosisA. Nusrath Unissa, Sameer Hassan, Luke Elizabeth Hanna 8) A Nanosensor System Based On Disuccinimydyl–CYP2E1 for Amperometric Detection of the Anti-Tuberculosis Drug, PyrazinamideR. F. Ajayi, U. Sidwaba, U. Feleni, S. F. Douman, E. Nxusani, L. Wilson, C. Rassie, O. Tovide, P. G. L. Baker, S. L. Vilakazi, R. Tshikhudo, E. I. Iwuoha 9) The Impact of Treatment of Latent Tuberculosis on the Incidence : The Case of AlgeriaSchehrazad Selmane 10) Molecular Docking Studies of Mycobacterium tuberculosis RNA Polymerase β Subunit (rpoB) ReceptorVirupakshaiah DBM, Madiha Ahmed, Smita T. Patil, Chandrakanth Kelmani 11) Tuberculosis Modelling Using Bio-PEPA ApproachDalila Hamami, Baghdad Atmani 12) Real-Time Detecting Concentration of Mycobacterium Tuberculosis by CNTFET BiosensorHsiao-Wei Wang, Jung-Tang Huang, Chun-Chiang Lin 13) Evaluation Rabbit Serum of the Immunodominant Proteins of Mycobacterium Avium Paratuberculosis ExtractsM. Hashemi, R. Madani, N. Razmi 14) The Lymphocytes Number in the Blood of Kwashiorkor Rat Model Induced by Oral Immunization with 38-kDa Mycobacterium tuberculosis ProteinNovi Khila Firani, Elisa Nesdyaningtyas 15) An in Silico Approach for Prioritizing Drug Targets in Metabolic Pathway of Mycobacterium TuberculosisBaharak Khoshkholgh-Sima, Soroush Sardari, Jalal Izadi Mobarakeh, Ramezan Ali Khavari-Nejad
Similar conferences about Medical and Health Sciences